Growth hormone measurements in the diagnosis and monitoring of acromegaly

Pituitary

Volumn 10, Issue 2, 2007, Pages 165-172

  Sata, Akira ^a   Ho, Ken K Y ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Acromegaly; Growth hormone; Insulin likegrowth factor I

Indexed keywords

BROMOCRIPTINE; GONADORELIN; GROWTH HORMONE; PROTIRELIN; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; DIAGNOSTIC VALUE; DISEASE SEVERITY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; MORTALITY; NORMAL VALUE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOM SAMPLE;

ACROMEGALY; DIAGNOSTIC TECHNIQUES, ENDOCRINE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS;

EID: 34249902790     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0034-x     Document Type: Article

References (56)

1. Ho KY, Weissberger AJ (1994) Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy. Clin Endocrinol (Oxf) 41:75-83
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
3. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
4. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K (2001) A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552
5. Tannenbaum GS, Epelbaum J, Bowers CY (2003) Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144:967-974
6. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
7. Duncan E, Wass JA (1999) Investigation protocol: Acromegaly and its investigation. Clin Endocrinol (Oxf) 50:285-293
8. Bertherat J, Bluet-Pajot MT, Epelbaum J (1995) Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132:12-24
9. Melmed SaK D (2003) (ed) Williams textbook of endocrinology 10th edn. Saunders, Philadelphia
10. Fiasche R, Fideleff HL, Moisezowicz J, Frieder P, Pagano SM, Holland M (1995) Growth hormone neurosecretory disfunction in major depressive illness. Psychoneuroendocrinology 20:727-733
11. Sakkas PN, Soldatos CR, Bergiannaki JD, Paparrigopoulos TJ, Stefanis CN (1998) Growth hormone secretion during sleep in male depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 22:467-483
12. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO (1988) Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968-975
13. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO, Veldhuis JD (1994) Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release. J Clin Invest 94:1277-1288
14. Hartman ML, Veldhuis JD, Vance ML, Faria AC, Furlanetto RW, Thorner MO (1990) Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy. J Clin Endocrinol Metab 70:1375-1384
15. Barkan AL, Stred SE, Reno K, Markovs M, Hopwood NJ, Kelch RP, Beitins IZ (1989) Increased growth hormone pulse frequency in acromegaly. J Clin Endocrinol Metab 69:1225-1233
16. Riedel M, Gunther T, von zur Muhlen A, Brabant G (1992) The pulsatile GH secretion in acromegaly: Hypothalamic or pituitary origin? Clin Endocrinol (Oxf) 37:233-239
17. Gelato MC, Oldfield E, Loriaux DL, Merriam GR (1990) Pulsatile growth hormone secretion in patients with acromegaly and normal men: The effects of growth hormone-releasing hormone infusion. J Clin Endocrinol Metab 71:585-590
18. Roelfsema F, de Boer H, Frolich M (1990) The influence of octreotide treatment on pulsatile growth hormone release in acromegaly. Clin Endocrinol (Oxf) 33:297-306
19. Ho PJ, Friberg RD, Barkan AL (1992) Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly. J Clin Endocrinol Metab 75:812-819
20. Yamada M, Monden T, Satoh T, Satoh N, Murakami M, Iriuchijima T, Kakegawa T, Mori M (1993) Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: Cloning and functional expression of the human thyrotropin-releasing hormone receptor gene. Biochem Biophys Res Commun 195:737-745
21. Le Dafniet M, Lefebvre P, Barret A, Mechain C, Feinstein MC, Brandi AM, Peillon F (1990) Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: Modulation by dopamine, haloperidol, and somatostatin. J Clin Endocrinol Metab 71:480-486
22. Pagesy P, Croissandeau G, Le Dafniet M, Peillon F, Li JY (1992) Detection of thyrotropin-releasing hormone (TRH) mRNA by the reverse transcription-polymerase chain reaction in the human normal and tumoral anterior pituitary. Biochem Biophys Res Commun 182:182-187
23. Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228
24. Ehrchen J, Peters A, Ludecke DK, Visser T, Bauer K (2000) Analysis of thyrotropin-releasing hormone-signaling components in pituitary adenomas of patients with acromegaly. J Clin Endocrinol Metab 85:2709-2713
25. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 85:526-529
26. Freda PU (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13:171-184
27. Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Bruce JN (2003) Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly. Pituitary 6:175-180
28. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL (2002) Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up. J Clin Endocrinol Metab 87:3537-3542
29. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:1645-1652
30. Stonesifer LD, Jordan RM, Kohler PO (1981) Somatomedin C in treated acromegaly: Poor correlation with growth hormone and clinical response. J Clin Endocrinol Metab 53:931-934
31. Jadresic A, Banks LM, Child DF, Diamant L, Doyle FH, Fraser TR, Joplin GF (1982) The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med 51:189-204
32. Quabbe HJ (1982) Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: Results in 230 patients. Clin Endocrinol (Oxf) 16:107-119
33. Nabarro JD (1987) Acromegaly. Clin Endocrinol (Oxf) 26:481-512
34. Stewart PM, Smith S, Seth J, Stewart SE, Cole D, Edwards CR (1989) Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay. Ann Clin Biochem 26(Pt 2):205-206
35. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO (1994) Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 78:1312-1319
36. Trainer PJ (2002) Editorial: Acromegaly-consensus, what consensus? J Clin Endocrinol Metab 87:3534-3536
37. Freda PU, Landman RE, Sundeen RE, Post KD (2001) Gender and age in the biochemical assessment of cure of acromegaly. Pituitary 4:163-171
38. Costa AC, Rossi A, Martinelli CE Jr, Machado HR, Moreira AC (2002) Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: Should we achieve strict normal GH levels for a biochemical cure? J Clin Endocrinol Metab 87:3142-3147
39. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58
40. Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS, Veldhuis JD (1994) Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 78:543-548
41. Irie M, Tsushima T (1972) Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J Clin Endocrinol Metab 35:97-100
42. De Marinis L, Mancini A, Bianchi A, Gentilella R, Valle D, Giampietro A, Zuppi P, Anile C, Maira G, Giustina A (2002) Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: A retrospective evaluation of 50 patients. Metabolism 51:616-621
43. Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70:965-977
44. Gelato MC, Ross JL, Malozowski S, Pescovitz OH, Skerda M, Cassorla F, Loriaux DL, Merriam GR (1985) Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short-term linear growth in children with GH deficiency. J Clin Endocrinol Metab 61:444-450
45. Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Hizuka N, Takano K, Wakabayashi I, Demura H, Ling N et al (1986) Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. J Clin Endocrinol Metab 63:167-173
46. Freda PU, Post KD, Powell JS, Wardlaw SL (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 83:3808-3816
47. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD (2004) Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 89:495-500
48. Melmed S (2001) Acromegaly and cancer: Not a problem? J Clin Endocrinol Metab 86:2929-2934
49. Jenkins PJ (2006) Cancers associated with acromegaly. Neuroendocrinology 83:218-223
50. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418
51. Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
52. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102
53. Bates AS, Van't Hoff W, Jones JM, Clayton RN (1993) An audit of outcome of treatment in acromegaly. Q J Med 86:293-299
54. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83:2730-2734
55. Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW (2003) Long-term treatment outcome in acromegaly. Growth Horm IGF Res 13:185-192
56. Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674